reglab/statecodes huggingface dataset:
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.631 - Use of Sealed Sources for Diagnosis

Current through Reg. 50, No. 138; July 16, 2024
The licensee is allowed to use the sealed sources listed
				  below, provided they are approved by and used as specified in, the Sealed
				  Source and Device Registry, for diagnostic medical uses, or in research in
				  accordance with an active IDE application accepted by the FDA and the
				  requirements of Rule  64E-5.612, F.A.C., are
				  met.
(1) Iodine 125 as a sealed source
				in a device for bone mineral analysis;
(2) Iodine 125 as a sealed source in a
				portable device for imaging;
(3)
				Gadolinium 153 as a sealed source in a device for bone mineral
				analysis;
(4) Americium 241 as a
				sealed source in a device for bone mineral analysis, or
(5) For isotopes or uses not listed in
				subsections  64E-5.631(1) through
				(4), F.A.C., above, the licensee must amend
				their radioactive materials license.
In order to use isotopes in accordance this rule, an
				  authorized user must satisfy the training and experience requirements specified
				  in Rule  64E-5.654 or
				   64E-5.657,
				  F.A.C.
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.743, Amended
					 2-11-10.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.632 - Use of Sources for Manual Brachytherapy

Current through Reg. 50, No. 138; July 16, 2024
The licensee is allowed to use the brachytherapy sources
				  listed below, provided they are approved by and used as specified in, the
				  Sealed Source and Device Registry for medical uses, or in research in
				  accordance with an active IDE application accepted by the FDA and the
				  requirements of Rule  64E-5.612, F.A.C., are
				  met.
(1) Cobalt 60 as a sealed source
				in needles and applicator cells for topical, interstitial, and intracavitary
				treatment of cancer;
(2) Strontium
				90 as a sealed source in an applicator for treatment of superficial eye
				conditions;
(3) Palladium 103 as a
				sealed source in seeds for interstitial treatment of cancer;
(4) Iodine 125 as a sealed source in seeds
				for interstitial treatment of cancer;
(5) Cesium 137 as a sealed source in needles
				and applicator cells for topical, interstitial, and intracavitary treatment of
				cancer;
(6) Iridium 192 as seeds
				encased in nylon ribbon for interstitial treatment of cancer;
(7) Gold 198 as a sealed source in seeds for
				interstitial treatment of cancer;
(8) Radon 222 as seeds for interstitial
				treatment of cancer;
(9) Radium 226
				as a sealed source in needles or applicator cells for topical, interstitial,
				and intracavitary treatment of cancer;
(10) Cesium 131 as a sealed source in seeds
				for interstitial treatment of cancer, or
(11) For isotopes or uses not listed in
				subsections  64E-5.632(1) through
				(10), F.A.C., above, the licensee must amend
				their radioactive materials license.
In order to use isotopes in accordance with Rule
				   64E-5.632, F.A.C., an authorized
				  user must satisfy the training and experience requirements specified in Rule
				   64E-5.652 or
				   64E-5.657, F.A.C. An authorized
				  user of only Strontium 90 as a sealed source in an applicator for treatment of
				  superficial eye conditions listed in subsection
				   64E-5.632(2),
				  F.A.C., above must satisfy the training and experience specified in Rule
				   64E-5.652,  64E-5.653 or
				   64E-5.657,
				  F.A.C.
Rulemaking Authority
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					  404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.745, Amended 2-11-10,
					 12-26-13.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.633 - Manual Brachytherapy Sources Inventory and Surveys

Current through Reg. 50, No. 138; July 16, 2024
(1) The licensee shall maintain
				accountability at all times for all manual brachytherapy sources in storage or
				use.
(a) As soon as possible each time
				brachytherapy sources are returned to an area of storage from an area of use,
				the licensee shall immediately count or otherwise verify the number returned to
				ensure that all sources taken from the storage area have been returned;
				and,
(b) As soon as possible after
				removing the sources from a patient or a human research subject, the licensee
				shall immediately count or otherwise verify the number of sources and return
				them to a secure storage area.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6331 - Calibration Measurements of Manual Brachytherapy Sources

Current through Reg. 50, No. 138; July 16, 2024
(1) Before the first medical use of a
				brachytherapy source, the licensee shall, using published protocols currently
				accepted by nationally recognized bodies, determine the following:
(a) Source output or activity using a
				dosimetry system that meets the requirements of subsection
				 64E-5.640(1),
				F.A.C.; and,
(b) Source positioning
				accuracy within applicators.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6332 - Decay of Strontium-90 Sources for Ophthalmic Treatments

Current through Reg. 50, No. 138; July 16, 2024
(1) Only an authorized medical physicist or
				authorized user qualified to perform procedures described in subsection
				 64E-5.632(2),
				F.A.C., shall calculate the activity of each strontium-90 source that is used
				to determine the treatment times for ophthalmic treatments. The decay must be
				based on the activity determined under Rule
				 64E-5.6331, F.A.C.
(2) For each Strontium 90 source the licensee
				shall retain the following records for the life of the source:
(a) The date and activity of the source as
				determined under Rule
				 64E-5.6331, F.A.C.;
				and,
(b) For each decay
				calculation, the date and the source activity as determined under Rule
				 64E-5.6332,
				F.A.C.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.634 - Use of a Sealed Source in a Remote Afterloader Unit, Teletherapy Unit, or Gamma Sterotactic Radiosurgery Unit

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee shall use sealed sources in
				photon emitting gamma stereotactic radiosurgery units for therapeutic medical
				uses:
(a) As approved in the Sealed Source and
				Device Registry, or
(b) In research
				in accordance with an active IDE application accepted by the FDA provided the
				requirements of Rule  64E-5.612, F.A.C. are
				met.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.635 - Installation, Adjustment, Maintenance and Repair Restrictions

Current through Reg. 50, No. 138; July 16, 2024
(1) Only a person specifically licensed by
				the NRC or an agreement state shall install, maintain, adjust, or repair a
				remote afterloader unit, teletherapy unit, or gamma stereotactic radiosurgery
				unit that involves work on the source(s) shielding, the source(s) driving unit,
				or other electronic or mechanical component that could expose the source(s),
				reduce the shielding around the source(s), or compromise the radiation safety
				of the unit or the source(s).
(2)
				Except for low dose-rate remote afterloader units, only a person specifically
				licensed by the NRC or an agreement state shall install, replace, relocate, or
				remove a sealed source or source contained in other remote afterloader units,
				teletherapy units, or gamma stereotactic radiosurgery units.
(3) For a low dose-rate remote afterloader
				unit, only a person specifically licensed by the NRC or an agreement state or
				an authorized medical physicist shall install, replace, relocate, or remove a
				sealed source(s) contained in the unit.
(4) A licensee shall retain a record of the
				installation, maintenance, adjustment, and repair of remote afterloader units,
				teletherapy units, and gamma stereotactic radiosurgery units for 3 years. For
				each installation, maintenance, adjustment and repair, the record must include
				the date, description of the service, and name(s) of the individual(s) who
				performed the work.
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.752, Amended
					 2-11-10.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.636 - Safety Procedures and Instructions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
(1) Listed below are the safety and
				instruction requirements for a licensee:
(a)
				Secure the unit, the console, the console keys, and the treatment room when not
				in use or unattended;
(b) Permit
				only individuals approved by the authorized user, RSO, or authorized medical
				physicist to be present in the treatment room during treatment with the
				source(s);
(c) Prevent dual
				operation of more than one radiation producing device in a treatment room if
				applicable; and,
(d) Develop,
				implement, and maintain written procedures for responding to an abnormal
				situation when the operator is unable to place the source(s) in the shielded
				position, or remove the patient or human research subject from the radiation
				field with controls from outside the treatment room. These procedures must
				include the following:
1. Instructions for
				responding to equipment failures and the names of the individuals responsible
				for implementing corrective actions;
2. The process for restricting access to and
				posting of the treatment area to minimize the risk of inadvertent exposure;
				and,
3. The names and telephone
				numbers of the authorized users, the authorized medical physicist, and the RSO
				to be contacted if the unit or console operates
				abnormally.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.637 - Safety Precautions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee shall control access to the
				treatment room by a door at each entrance.
(2) A licensee shall equip each entrance to
				the treatment room with an electrical interlock system that shall:
(a) Prevent the operator from initiating the
				treatment cycle unless each treatment room entrance door is closed;
(b) Cause the source(s) to be shielded when
				an entrance door is opened; and,
(c) Prevent the source(s) from being exposed
				following an interlock interruption until all treatment room entrance doors are
				closed and the source(s) on-off control is reset at the
				console.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.638 - Radiation Monitoring Devices

Current through Reg. 50, No. 138; July 16, 2024
(1) A
				licensee shall have a permanent radiation monitor in each teletherapy, medium
				or high dose rate remote afterloader, or gamma stereotactic radiosurgery room
				capable of continuously monitoring radiation levels.
(2) Each radiation monitor shall be capable
				of providing visible notice of a teletherapy unit, medium or high dose rate
				remote afterloader unit, or gamma stereotactic radiosurgery unit malfunction
				that results in an exposed or partially exposed source. The visible indicator
				of high radiation levels shall be observable by an individual entering the
				teletherapy, medium or high dose rate remote afterloader, or gamma stereotactic
				radiosurgery room.
(3) Each
				radiation monitor shall be equipped with a backup power supply separate from
				the power supply to the teletherapy unit, medium or high dose rate remote
				afterloader unit, or gamma stereotactic radiosurgery unit. This backup power
				supply may be a battery system.
(4)
				Each radiation monitor shall be checked daily with a dedicated check source for
				proper operation before the teletherapy unit, medium or high dose rate remote
				afterloader unit, or gamma stereotactic radiosurgery unit is used.
(5) A licensee shall maintain a record of the
				check required by subsection
				 64E-5.638(4),
				F.A.C., for 3 years. The record shall include the date of the check, notation
				what the monitor indicates when its detector is and is not exposed to the
				source, and the initials of the individual who performed the check.
(6) If a radiation monitor is inoperable, the
				licensee shall require any individual entering the teletherapy, medium or high
				dose rate remote afterloader, or gamma stereotactic radiosurgery room to use a
				radiation survey instrument or audible alarm personal dosimeter to monitor for
				any malfunction of the source exposure mechanism that may result in an exposed
				or partially exposed source. The radiation survey instrument or dosimeter shall
				be checked with a dedicated check source for proper operation at the beginning
				of each day of use. The licensee shall keep a record as described in subsection
				 64E-5.638(5),
				F.A.C.
(7) A licensee shall
				promptly repair or replace the radiation monitor if it is
				inoperable.
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.757, Amended
					 2-11-10.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.639 - Viewing Systems

Current through Reg. 50, No. 138; July 16, 2024
A licensee shall construct or equip each teletherapy, medium
				  or high dose rate remote afterloader, or gamma stereotactic radiosurgery room
				  to permit continuous observation of the patient, or human research subject from
				  the teletherapy unit console during irradiation.
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.758, Amended
					 2-11-10.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.640 - Dosimetry Equipment Used With Remote Afterloading Units, Teletherapy Units, or Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
(1) Except for low dose-rate remote
				afterloader source output or where the activity is determined by the
				manufacturer, a licensee shall have a dosimetry system available for use
				calibrated by paragraph (a) or (b), below.
(a) The system must have been calibrated
				using a system or source traceable to the NIST and published protocols accepted
				by nationally recognized bodies; or by a calibration laboratory accredited by
				the AAPM. The calibration must have been performed within the previous 2 years
				and after any servicing that may have affected system calibration.
(b) The system shall have been calibrated
				within the previous 4 years and shall have been intercompared 18 to 30 months
				after the calibration at an intercomparison meeting with another dosimetry
				system that has been calibrated within the previous 2 years by the NIST or by a
				calibration laboratory accredited by the AAPM. The intercomparison meeting
				shall be sanctioned by a calibration laboratory or radiologic physics center
				accredited by the AAPM. The calibration factor of the licensee's system shall
				not have changed by more than 2 percent. The licensee shall not use the
				intercomparison result to change the calibration factor. When intercomparing
				dosimetry systems to be used for calibrating sealed sources for therapeutic
				units, the licensee shall use a comparable unit with beam attenuators or
				collimators, as applicable, and sources of the same radionuclide as the source
				used at the licensee's facility.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.641 - Full Calibration Measurements on Teletherapy Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee authorized to use a
				teletherapy unit for medical use shall perform full calibration measurements on
				each teletherapy unit:
(a) Before the first
				medical use of the unit;
(b) Before
				medical use whenever spot-check measurements indicate that the output differs
				by more than 5 percent from the output obtained at the last full calibration
				corrected mathematically for radioactive decay;
(c) Before medical use following replacement
				of the source or following reinstallation of the teletherapy unit in a new
				location;
(d) Before medical use
				following any repair of the teletherapy unit that includes removal of the
				source or major repair of the components associated with the source exposure
				assembly; and,
(e) At least every
				12 months.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6411 - Full Calibration Measurements on Remote Afterloader Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee authorized to use a remote
				afterloader unit for medical use shall perform full calibration measurements on
				each remote afterloader unit:
(a) Before the
				first medical use of the unit;
(b)
1. Before medical use following replacement
				of the source or following reinstallation of the unit in a new location outside
				the facility; and,
2. Before
				medical use following any repair of the unit that includes removal of the
				source or major repair of the components associated with the source exposure
				assembly; and,
(c) At
				intervals not exceeding 1 quarter for high dose-rate, medium dose-rate, and
				pulsed dose-rate remote afterloader units with sources whose half-life exceeds
				75 days; and,
(d) At intervals not
				exceeding 1 year for low dose-rate remote afterloader
				units.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6412 - Full Calibration Measurements on Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee
				authorized to use a gamma stereotactic radiosurgery unit for medical use shall
				perform full calibration measurements on each gamma stereotactic radiosurgery:
(a) Before the first medical use of the
				unit;
(b)
1. Before medical use whenever spot-check
				measurements indicate that the output differs by more than 5 percent from the
				output obtained at the last full calibration corrected mathematically for
				radioactive decay;
2. Before
				medical use following replacement of the source or following reinstallation of
				the gamma stereotactic radiosurgery unit in a new location;
3. Following any repair of the gamma
				stereotactic radiosurgery unit that includes removal of the sources or major
				repair of the components associated with the source assembly;
				and
(c) At intervals not
				exceeding 1 year, with the exception that relative helmet factors need only be
				determined before the first medical use of a helmet and following any damage to
				a helmet.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.642 - Periodic Spot-Checks or Teletherapy Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee authorized to use teletherapy
				units for medical use shall perform output spot-checks on each teletherapy unit
				at least every month.
(2)
				Spot-checks shall include the determination of:
(a) Timer constancy and timer linearity over
				the range of use;
(b) On-off
				error;
(c) The coincidence of the
				radiation field and the field indicated by the light beam localizing
				device;
(d) The accuracy of all
				distance measuring and localization devices used for medical use;
(e) The output for one typical set of
				operating conditions; and
(f) The
				difference between the measurement made in paragraph
				 64E-5.642(2)(e),
				F.A.C., and the anticipated output, expressed as a percentage of the
				anticipated output, which is the value obtained at the last full calibration
				corrected mathematically for physical decay.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6421 - Periodic Spot-Checks for Remote Afterloader Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee authorized to use a remote
				afterloader unit for medical use shall perform the following spot-checks:
(a) Before the first use of a high dose-rate,
				medium dose-rate, or pulsed dose-rate remote afterloader unit on a given
				day;
(b) Before each patient
				treatment with a low dose-rate remote afterloader unit; and
(c) After each source
				installation.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6422 - Periodic Spot-Checks for Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee authorized to use a gamma
				stereotactic radiosurgery unit for medical use shall perform the following
				spot-checks:
(a) Monthly:
(b) Before the first use of the unit on a
				given day; and
(c) After each
				source installation.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.6423 - Additional Technical Requirements for Mobile Remote Afterloader Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee providing mobile remote
				afterloader service for medical use shall perform the following:
(a) Check survey instruments before medical
				use at each address of use or on each day of use, whichever is more frequent;
				and
(b) Account for all sources
				before departure from a client's address of use.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.643 - Radiation Surveys for Teletherapy Facilities

Current through Reg. 50, No. 138; July 16, 2024
(1) The licensee shall perform radiation
				surveys with an operable radiation survey instrument calibrated as provided in
				Rule  64E-5.615, F.A.C., before
				medical use, after each installation of a teletherapy source; following repairs
				to the source(s) driving unit, or other electronic or mechanical component that
				could expose the source(s), reduce shielding around the source(s), or
				compromise the radiation safety of the unit or the source(s); and after making
				any change for which an amendment is required by Rule
				 64E-5.636, F.A.C.
(a) The maximum and average radiation levels
				from the surface of the main source(s) safe with the source(s) in the shielded
				position do not exceed the levels stated in the Sealed Source and Device
				Registry.
(b) With the teletherapy
				source in the on position with the largest clinically available treatment field
				and with a scattering phantom in the primary beam of radiation, radiation
				levels in restricted areas shall be unlikely to cause any occupationally
				exposed individuals to receive a dose in excess of the limits specified in Rule
				 64E-5.304, F.A.C.; and radiation
				dose rates of any individual member of the public in unrestricted areas shall
				not exceed the limits specified in paragraph
				 64E-5.312(1)(c),
				F.A.C.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.644 - Radiation Surveys for Remote Afterloader and Gamma Stereotactic Radiosurgery Facilities

Current through Reg. 50, No. 138; July 16, 2024
(1) The licensee
				shall perform radiation surveys with an operable radiation survey instrument
				calibrated as provided in Rule
				 64E-5.615, F.A.C., to ensure
				that the maximum radiation levels and average radiation levels from the surface
				of the main source safe with the source(s) in the shielded position do not
				exceed the levels stated in the Sealed Source and Device Registry.
(2) The licensee shall make the survey
				specified in subsection
				 64E-5.644(1),
				F.A.C., at the installation of a new source and following repairs to the
				source(s) shielding, the source(s) driving unit, or other electronic or
				mechanical component that could expose the source, reduce the shielding around
				the source(s), or compromise the radiation safety of the unit or the
				source(s).
(3) A licensee shall
				retain a record of the radiation surveys required by subsection
				 64E-5.644(1),
				F.A.C., for the duration of the license. These records shall include:
(a) The date of the measurements;
(b) The manufacturer's name, model number and
				serial number of the treatment unit, source, and instrument used to measure
				radiation levels;
(c) Each dose
				rate measured around the source while the unit is in the off position and the
				average of all measurements; and
(d) The signature of the RSO or authorized
				medical physicist who performed the test.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.645 - Remote Afterloader, Gamma Stereotactic, and Teletherapy Therapy-Related Computer Systems

Current through Reg. 50, No. 138; July 16, 2024
The licensee shall perform acceptance testing on the
				  treatment planning system of high, medium, low, pulsed dose-rate remote
				  afterloaders, gamma stereotactic, and teletherapy therapy-related computer
				  systems in accordance with published protocols accepted by nationally
				  recognized bodies. An example of a nationally recognized body is the American
				  Association of Physicists in Medicine. At a minimum, the acceptance testing
				  must include, as applicable, verification of the following:
(1) The source-specific input parameters
				required by the dose calculation algorithm;
(2) The accuracy of dose, dwell time, and
				treatment time calculations at representative points;
(3) The accuracy of isodose plots and graphic
				displays;
(4) The accuracy of the
				software used to determine sealed source positions from radiographic images;
				and
(5) The accuracy of electronic
				transfer of the treatment delivery parameters to the treatment delivery unit
				from the treatment planning system.
Rulemaking Authority
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					  404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Amended 1-1-94, Formerly 10D-91.764, Amended
					 10-8-00, 2-11-10, 12-26-13.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.646 - Reports of Teletherapy Surveys, Checks, Tests, and Measurements

Current through Reg. 50, No. 138; July 16, 2024
A licensee shall furnish a copy of the records required in
				  Rules  64E-5.643,
				   64E-5.644, and
				   64E-5.645, F.A.C., and the
				  output from the teletherapy source expressed as rads (grays) per hour at 1
				  meter from the source as determined during the full calibration required in
				  Rule  64E-5.641, F.A.C., to the
				  department within 30 days following completion of the action that initiated the
				  record requirement.
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
8-25-91, Formerly
					 10D-91.765.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.647 - Five Year Inspection for Teletherapy and Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
(1) A licensee shall
				have each teletherapy unit and gamma stereotactic radiosurgery unit fully
				inspected and serviced during source replacement or at least every 5 years,
				whichever comes first, to assure proper functioning of the source exposure
				mechanism.
(2) This inspection and
				servicing shall only be performed by persons specifically licensed to do so by
				the department, an agreement state, or the U.S. Nuclear Regulatory
				Commission.
(3) A licensee shall
				maintain a record of the inspection and servicing for the duration of the
				license. The record shall contain:
(a) The
				inspector's name;
(b) The
				inspector's radioactive materials license number;
(c) The date of inspection;
(d) The manufacturer's name and model number
				and serial number for both the treatment unit and source;
(e) A list of components inspected;
(f) A list of components serviced and the
				type of service;
(g) A list of
				components replaced; and
(h) The
				signature of the inspector.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.648 - Radiation Safety Officer

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the RSO as provided in Rule
				   64E-5.605, F.A.C., to be an
				  individual who:
(1) Is certified by a
				specialty board whose certification process has been recognized by the NRC or
				an agreement state and who meets the requirements in subsections
				 64E-5.648(4) and
				(5), F.A.C., of this section. (The names of
				board certifications which have been recognized by the NRC or an agreement
				state will be posted on the NRC's Web page at
http://www.nrc.gov/materials/miau/
med-use-toolkit/spec-board-cert.html.) To have its certification process
				recognized, a specialty board shall require all candidates for certification
				to:
(a)
1.
				Hold a bachelor's or graduate degree from an accredited college or university
				in physical science or engineering or biological science with a minimum of 20
				college credits in physical science;
2. Have 5 or more years of professional
				experience in health physics (graduate training may be substituted for no more
				than 2 years of the required experience) including at least 3 years in applied
				health physics; and
3. Pass an
				examination administered by diplomates of the specialty board, which evaluates
				knowledge and competence in radiation physics and instrumentation, radiation
				protection, mathematics pertaining to the use and measurement of radioactivity,
				radiation biology, and radiation dosimetry; or
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.649 - Training for Uptake, Dilution, or Excretion Studies

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized user of a radiopharmaceutical listed in subsection
				   64E-5.626(1),
				  F.A.C., to:
(1) Be certified by a
				medical specialty board whose certification process has been recognized by the
				NRC or an agreement state and who meets the requirements in paragraph
				 64E-5.649(3)(b),
				F.A.C., of this section. (The names of board certifications which have been
				recognized by the NRC or an agreement state will be posted on the NRC's Web
				page at
http://www.nrc.gov/
materials/miau/med-use-toolkit/spec-board-cert.html.) To have its certification
				process recognized, a specialty board shall require all candidates for
				certification to:
(a) Complete 60 hours of
				training and experience in basic radionuclide handling techniques and radiation
				safety applicable to the medical use of unsealed radioactive material for
				uptake, dilution, and excretion studies that includes the topics listed in
				paragraph  64E-5.649(3)(a) 
				and subparagraph  64E-5.649(3)(a) 
				2., F.A.C., of this section; and
(b) Pass an examination, administered by
				diplomates of the specialty board, that assesses knowledge and competence in
				radiation safety, radionuclide handling, and quality control;
				or
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.650 - Training for Imaging and Localization Studies for Which a Written Directive Is Not Required

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized user specified in subsection
				   64E-5.627(1),
				  F.A.C., to:
(1) Be certified by a
				medical specialty board whose certification process has been recognized by the
				NRC or an agreement state and who meets the requirements in paragraph
				 64E-5.650(3)(b),
				F.A.C., of this section. (The names of board certifications which have been
				recognized by the NRC or an agreement state will be posted on the NRC's Web
				page at
http://www.nrc.gov/
materials/miau/med-use-toolkit/spec-board-cert.html.) To have its certification
				process recognized, a specialty board shall require all candidates for
				certification to:
(a) Complete 700 hours of
				training and experience in basic radionuclide handling techniques and radiation
				safety applicable to the medical use of unsealed radioactive material for
				imaging and localization studies that includes the topics listed in
				subparagraphs  64E-5.650(3)(a) 
				1. and  64E-5.650(3)(a) 
				2., F.A.C., of this section; and
(b) Pass an examination, administered by
				diplomates of the specialty board, which assesses knowledge and competence in
				radiation safety, radionuclide handling, and quality control;
				or
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.651 - Training for Therapeutic Use of Radiopharmaceuticals (Repealed)

Current through Reg. 50, No. 138; July 16, 2024
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.771, Repealed
					 2-11-10.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.652 - Training for Use of Manual Brachytherapy Sources

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized user of a brachytherapy source specified in Rule
				   64E-5.632, F.A.C., to:
(1) Be certified by a medical specialty board
				whose certification process has been recognized by the NRC or an agreement
				state, and who meets the requirements in paragraph
				 64E-5.652(2)(c),
				F.A.C., of this section. (The names of board certifications which have been
				recognized by the NRC or an agreement state will be posted on the NRC's Web
				page at
http://www.nrc.gov/materials/
miau/med-use-toolkit/spec-board-cert.html.) To have its certification process
				recognized, a specialty board shall require all candidates for certification
				to:
(a) Successfully complete a minimum of 3
				years of residency training in a radiation oncology program approved by the
				Residency Review Committee of the Accreditation Council for Graduate Medical
				Education or the Royal College of Physicians and Surgeons of Canada or the
				Committee on Post-Graduate Training of the American Osteopathic Association;
				and
(b) Pass an examination,
				administered by diplomates of the specialty board, that tests knowledge and
				competence in radiation safety, radionuclide handling, treatment planning,
				quality assurance, and clinical use of manual brachytherapy;
				or
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.653 - Training for Ophthalmic Use of Strontium 90

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized user of only strontium 90 for ophthalmic
				  radiotherapy to:
(1) Be authorized
				user under Rule  64E-5.652, F.A.C., NRC or
				equivalent Agreement State requirements; or
(2)
(a)
				Have completed 24 hours of classroom and laboratory training applicable to the
				medical use of strontium-90 for ophthalmic radiotherapy. The training must
				include the following:
1. Radiation physics
				and instrumentation:
2. Radiation
				protection;
3. Mathematics
				pertaining to the use and measurement of radioactivity; and
4. Radiation biology; and
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.654 - Training for Use of Sealed Sources for Diagnosis

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized user of a sealed source in a device specified in
				  Rule  64E-5.631, F.A.C., to be a
				  physician, dentist, or podiatrist:
(1)
				Be certified by a specialty board whose certification process includes all of
				the requirements in subsections
				 64E-5.654(2) and
				(3), F.A.C., of this section and whose
				certification has been recognized by the NRC or an agreement state. (The names
				of board certifications which have been recognized by the NRC or an agreement
				state will be posted on the NRC's Web page at
http://www.nrc.gov/materials/miau/med-use-toolkit/spec-board-cert.html
.);
				or
(2) Have completed 8 hours of
				classroom and laboratory training in basic radionuclide handling techniques
				specifically applicable to the use of the device. The training must include the
				following:
(a) Radiation physics and
				instrumentation;
(b) Radiation
				protection;
(c) Mathematics
				pertaining to the use and measurement of radioactivity; and
(d) Radiation biology;
				and
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.655 - Training for Use of Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized user of a sealed source specified in Rule
				   64E-5.634, F.A.C., to:
(1) Be certified by a medical specialty board
				whose certification process has been recognized by the NRC or an agreement
				state and who meets the requirements in paragraph
				 64E-5.655(2)(c) 
				and subsection  64E-5.655(3),
				F.A.C., of this section. (The names of board certifications which have been
				recognized by the NRC or an agreement state will be posted on the NRC's Web
				page at
http://www.nrc.gov/materials/miau/med-use-toolkit/spec-board-cert.html
.)
				To have its certification process recognized, a specialty board shall require
				all candidates for certification to:
(a)
				Successfully complete a minimum of 3 years of residency training in a radiation
				therapy program approved by the Residency Review Committee of the Accreditation
				Council for Graduate Medical Education or the Royal College of Physicians and
				Surgeons of Canada or the Committee on Post-Graduate Training of the American
				Osteopathic Association; and
(b)
				Pass an examination, administered by diplomates of the specialty board, which
				tests knowledge and competence in radiation safety, radionuclide handling,
				treatment planning, quality assurance, and clinical use of stereotactic
				radiosurgery, remote afterloaders and external beam therapy;
				or
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.656 - Training for and Authorized Medical Physicist

Current through Reg. 50, No. 138; July 16, 2024
Except as provided in Rule
				   64E-5.657, F.A.C., the licensee
				  shall require the authorized medical physicist to:
(1) Be certified by a specialty board whose
				certification process has been recognized by the NRC or an agreement state and
				who meets the requirements in paragraph
				 64E-5.656(2)(b) 
				and subsection  64E-5.656(3),
				F.A.C., of this section. (The names of board certifications which have been
				recognized by the NRC or an agreement state will be posted on the NRC's Web
				page at
http://www.nrc.gov/materials/miau/med-use-toolkit/spec-board-cert.html
.)
				To have its certification process recognized, a specialty board shall require
				all candidates for certification to:
(a) Hold
				a master's or doctor's degree in physics, medical physics, other physical
				science, engineering, or applied mathematics from an accredited college or
				university;
(b) Have 2 years of
				full-time practical training and/or supervised experience in medical physics:
1. Under the supervision of a medical
				physicist who is certified in medical physics by a specialty board recognized
				by the NRC or an agreement state; or
2. In clinical radiation facilities providing
				high-energy, external beam therapy (photons and electrons with energies greater
				than or equal to 1 million electron volts) and brachytherapy services under the
				direction of physicians who meet the requirements for authorized users in Rule
				 64E-5.657,
				 64E-5.652 or
				 64E-5.655, F.A.C.;
				and
(c) Pass an
				examination, administered by diplomates of the specialty board, that assesses
				knowledge and competence in clinical radiation therapy, radiation safety,
				calibration, quality assurance, and treatment planning for external beam
				therapy, brachytherapy, and stereotactic radiosurgery; or
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.657 - Training for Experienced RSO, Teletherapy or Medical Physicist, Authorized Medical Physicist, Authorized User, Nuclear Pharmacist, and Authorized Nuclear Pharmacist

Current through Reg. 50, No. 138; July 16, 2024
(1)
(a) An individual identified as a RSO, a
				teletherapy or medical physicist, or a nuclear pharmacist on a NRC or agreement
				state license or a permit issued by a NRC or agreement state broad scope
				licensee or master material license permit or by a master material license
				permittee of broad scope, need not comply with the training requirements of
				Rule  64E-5.648,
				 64E-5.656 or
				 64E-5.659, F.A.C.,
				respectively.
(b) An individual
				identified as a RSO, an authorized medical physicist, or an authorized nuclear
				pharmacist on a NRC or agreement state license or a permit issued by a NRC or
				agreement state broad scope licensee or master material license permit or by a
				master material license permittee of broad scope, need not comply with the
				training requirements of Rule
				 64E-5.648,
				 64E-5.656 or
				 64E-5.659, F.A.C.,
				respectively.
Florida Administrative Code › 64 - DEPARTMENT OF HEALTH › 64E - Division of Environmental Health › Chapter 64E-5 - CONTROL OF RADIATION HAZARDS › Section 64E-5.658 - Recentness of Training

Current through Reg. 50, No. 138; July 16, 2024
The training and experience specified in Rules
				   64E-5.648,
				   64E-5.649,
				   64E-5.650,
				   64E-5.652,
				   64E-5.653,
				   64E-5.654,
				   64E-5.655,
				   64E-5.656,
				   64E-5.657,
				   64E-5.659,
				   64E-5.660,
				   64E-5.661,
				   64E-5.662 and
				   64E-5.663, F.A.C., shall have
				  been obtained within the 7 years preceding the date of application or the
				  individual shall have had related continuing education or experience since the
				  required training and experience was completed and within the 7 years preceding
				  the date of application.
Rulemaking Authority
					  404.022,
					 404.051,
					 404.061,
					 404.071,
					 404.081,
					 404.141 FS. Law Implemented
					 404.022,
					  404.051(1), (4), (5), (6), (8), (9), (10),
					 (11),
					  404.061(2),
					 (3),
					  404.071(1),
					  404.081,
					  404.141 FS.
New 8-25-91, Formerly 10D-91.779, Amended
					 2-11-10.